Companies / Arthrex

Arthrex coverage

18 issues

• AOFAS Savannah Preview: MIS Achilles and the New Launches

  Unsolicited advice for exhibitors and surgeons, plus a challenger to Arthrex PARS.

• AOFAS Vancouver Preview: Sneak Peeks from the Exhibit Hall

  Product releases before they hit the floor, plus a new social platform for surgeons.

• The Artelon Playbook: How to Engineer an Exit

  Stryker pulls the trigger. Here is the five-step playbook that got Artelon there.

• Year-End Launches: DJO Nitinol, a Treace Plate, and Stryker Anchors

  Q4 is usually about hitting numbers. This one brought real products instead.

• The Syndesmosis Market, Reviewed

  The soft tissue battle heats up as Paragon 28 and Medline UNITE debut new products.

• The CMS Amniotic Clawback Is Coming

  Medicare wants its money back, plus a new surgeon CMO and a run of fresh launches.

• ACFAS in Austin: Product Launches and Little Guys

  FAN worked the floor in Austin. Here is what was actually worth stopping for.

• CrossRoads Sells to DePuy Synthes, Plus the Bunion DTC Marketing War

  J&J finally makes its move, and a look at who is winning direct-to-patient.

• Breaking: Arthrex's New MIS Release

  The first time FAN broke product news instead of reporting someone else's.

• Grading the December Product Launches

  Technology, company impact, and market fit — grading the launches that missed awards season.

• Golden Demobone Awards: Treace Takes Rotational Bunion, Plus a Market Share Read

  A winner in the year's most contested category, plus where market share is heading.

• Golden Demobone Awards: Rotational Bunion and MIS Products of the Year

  The two hottest markets in foot and ankle go head to head for hardware of the year.

• Golden Demobone Awards: Acquisition of the Year

  The votes are in on the year's biggest deal, and two new categories open.

• Introducing the Golden Demobone Awards

  FAN's first annual awards for the products, people, and deals that defined the year.

• The Nitinol Wars: CrossRoads, MedShape, and Arthrex Escalate

  Everyone has a nitinol staple. These three are trying to do more with it.

• Surgical Volumes Rebound, and a New Total Ankle Enters the Field

  Case volumes recover faster than forecast, plus a CE mark and a new total ankle.

• Arthrex Goes Direct-to-Patient with AnkleSprain.com

  Two million ankle sprains a year, and a company building the landing page for them.

• MIS Bunion Systems Compared: Arthrex, Novastep, and Wright Medical

  A side-by-side look at the three MIS bunion platforms currently on the market.